Table 3.

Baseline type-specific HPV infection distribution by country

BrazilMexicoUnited StatesTotal
(N = 475)(N = 591)(N = 614)(N = 1,680)
Carcinogenica
 163 (0.6)3 (0.5)4 (0.7)10 (0.6)
 311 (0.2)1 (0.1)
 351 (0.2)1 (0.1)
 391 (0.2)1 (0.1)
 511 (0.2)1 (0.2)1 (0.2)3 (0.2)
 521 (0.2)1 (0.1)
 561 (0.2)1 (0.2)2 (0.1)
 581 (0.2)1 (0.1)
 592 (0.3)2 (0.1)
Noncarcinogenica
 61 (0.2)1 (0.2)2 (0.1)
 111 (0.2)1 (0.1)
 531 (0.2)1 (0.1)
 5518 (3.0)1 (0.2)19 (1.1)
 611 (0.2)3 (0.5)4 (0.2)
 623 (0.5)1 (0.2)4 (0.2)
 641 (0.2)1 (0.1)
 661 (0.2)1 (0.2)1 (0.2)3 (0.2)
 691 (0.2)1 (0.1)
 701 (0.2)1 (0.2)2 (0.1)
 711 (0.2)2 (0.3)3 (0.2)
 724 (0.7)4 (0.2)
 821 (0.2)1 (0.1)
 841 (0.2)3 (0.5)4 (0.2)
 891 (0.2)1 (0.1)

NOTE: The given values are represented as number (percentages).

  • aHPV types 18, 33, 45, 68, 26, 40, 42, 54, 67, 73, 81, 82, and 83, were not detected in any of the oral specimens and were excluded from the table.